Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew A. Powell, MD
Washington University Siteman Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Iwate Medical University Hospital
Morioka, Iwate, Japan
- Kagoshima City Hospital
Kagoshima City, Kagoshima, Japan
- Kobe Medical Center
Kobe, Japan
- National Hospital Organization - Medical Center of Kure
Kure, Japan
- Shikoku Cancer Center
Matsuyama, Japan
- National Kyushu Cancer Center
Minamiku, Japan
- Kinki University School of Medicine
Osaka, Osaka, Japan
- Hokkaido University Hospital
Sapporo, Japan
- Tohoku University Graduate School of Medicine
Sendai, Japan
- Keio University School of Medicine
Shinjuku-ku, Japan
- Tottori University Hospital
Tottori, Japan
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- St. Vincent'S Medical Center
Jacksonville, Florida, United States
- Mbccop - Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
- James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, United States
- Woman'S Hospital
Baton Rouge, Louisiana, United States
- Union Hospital Cancer Program at Union Hospital
Elkton, Maryland, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Mecosta County Medical Center
Big Rapids, Michigan, United States
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Genesys Hurley Cancer Institute
Flint, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2005
- Primary completion
- 31 Jul 2010
- Completion
- —
- Last update posted
- 25 Sept 2018
- Registered enrollment
- 55
- Registry id
- NCT00112489
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.